Skip to main content
Top
Published in: High Blood Pressure & Cardiovascular Prevention 3/2008

01-07-2008 | Contributions from International Congress

5.13 Arterial Hypertension and Hyperhomocysteinaemia with TT Polymorphism of the C677T Gene for the 5-10-Methylenetetrahydrofolate Reductase: Risk Factors able to influence Clinical Management of the Patent Foramen Ovale?

Authors: A. Mazza, S. Zamboni, S. Cuppini, M. Armigliato, P. Rempelou, A. Camerotto, M. Gusella, A.C. Pessina, V. Tikhonoff, E. Casiglia

Published in: High Blood Pressure & Cardiovascular Prevention | Issue 3/2008

Login to get access

Excerpt

Introduction. In subjects aged <55 years, the association between patent foramen ovale (PFO) and cryptogenetic cerebrovascular (CV) events is well established. In the clinical management of the PFO, a thrombophilic screening including homocysteinaemia (Hcy) determination and methylenetetrahydrofolate reductase polymorphism (MTHFR) evaluation for the C677T gene are recommended. …
Metadata
Title
5.13 Arterial Hypertension and Hyperhomocysteinaemia with TT Polymorphism of the C677T Gene for the 5-10-Methylenetetrahydrofolate Reductase: Risk Factors able to influence Clinical Management of the Patent Foramen Ovale?
Authors
A. Mazza
S. Zamboni
S. Cuppini
M. Armigliato
P. Rempelou
A. Camerotto
M. Gusella
A.C. Pessina
V. Tikhonoff
E. Casiglia
Publication date
01-07-2008
Publisher
Springer International Publishing
Published in
High Blood Pressure & Cardiovascular Prevention / Issue 3/2008
Print ISSN: 1120-9879
Electronic ISSN: 1179-1985
DOI
https://doi.org/10.1007/BF03263633

Other articles of this Issue 3/2008

High Blood Pressure & Cardiovascular Prevention 3/2008 Go to the issue